Table 3.
Moderator | Level | No. of Studies | SMD | 95% CI | I2 | Homogeneity Test | ||
---|---|---|---|---|---|---|---|---|
Q | df | p | ||||||
Mode of combination | Sequential | 9 | 0.27 ** | 0.10 to 0.44 | 0 | 0.01 | 1 | 0.94 |
Simultaneous | 8 | 0.26 ** | 0.08 to 0.44 | 49.53 | ||||
Cognitive status | Healthy | 11 | 0.33 ** | 0.16 to 0.50 | 23.28 | 1.22 | 1 | 0.27 |
MCI | 6 | 0.19 * | 0.01 to 0.37 | 6.74 | ||||
Control group | Active | 8 | 0.27 ** | 0.11 to 0.43 | 14.52 | 0.03 | 1 | 0.86 |
Passive | 9 | 0.25 * | 0.05 to 0.45 | 29.78 | ||||
Intervention length | Long (≥24 weeks) | 5 | 0.11 | −0.07 to 0.29 | 0 | 4.92 | 2 | 0.09 |
Medium (12–23 weeks) | 8 | 0.37 ** | 0.17 to 0.56 | 39 | ||||
Short (<12 weeks) | 4 | 0.44 * | 0.12 to 0.75 | 0 | ||||
Frequency | High (>3 sessions/week) | 3 | 0.21 | −0.07 to 0.48 | 0 | 0.2 | 1 | 0.66 |
Low (≤3 sessions/week) | 14 | 0.28 * | 0.14 to 0.41 | 32.92 | ||||
Session duration | Long (>60 min) | 7 | 0.20 | −0.02 to 0.41 | 0 | 4.13 | 2 | 0.13 |
Medium (>30 to ≤60 min) | 8 | 0.41 ** | 0.22 to 0.61 | 30.47 | ||||
Short (≤30 min) | 2 | 0.11 | −0.13 to 0.35 | 0 | ||||
Study quality | High (≥9 scores) | 13 | 0.26 ** | 0.13 to 0.39 | 36.65 | 0.01 | 1 | 0.91 |
Low (<9 scores) | 4 | 0.28 | −0.05 to 0.61 | 0 |
* p < 0.05, ** p < 0.05.